OFF-LABEL PEDIATRIC DRUG USE IN INDONESIA : A SYSTEMATIC REVIEW
The phenomenon of off-label drug use has been widely observed in the pediatric population, including in Indonesia. The major concern arising from the prevalence of off-label drug use is the increased risk of adverse drug reactions. We performed a systematic review to describe and provide insight in...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Indonesian |
| Published: |
Universitas Muhammadiyah Magelang
2020-04-01
|
| Series: | Jurnal Farmasi Sains dan Praktis |
| Subjects: | |
| Online Access: | http://journal.ummgl.ac.id/index.php/pharmacy/article/view/3407 |
| Summary: | The phenomenon of off-label drug use has been widely observed in the pediatric population, including in Indonesia. The major concern arising from the prevalence of off-label drug use is the increased risk of adverse drug reactions. We performed a systematic review to describe and provide insight into off-label pediatric drug use in Indonesia. The articles published using English and Bahasa Indonesia were systematically searched in five electronic databases including Pubmed, Scopus, Google Scholar, Garuda, and Neliti. Key terms used for the search were as follows: “off-label use”, “off-label, “child", "pediatrics", "infant", "adolescent", ”newborn”, “Indonesia”. A total of 116 studies were initially obtained from electronic databases. Further, after the references were reviewed, 10 articles met all the eligibility criterias were finally selected. The percentage of off-label pediatric drug use was 32.6-89.9%. The off-label categories in the selected studies were age, dosage, contraindication, route of administration, and indication. Among these off-label categories, age was the highest off-label with percentages ranged from 19.8 to 92.9%. Pseudoephedrine hydrochloride and triamcinolone acetonide became the most frequently used drug in that category. Thus we conclude that off-label pediatric drug use is common in Indonesia. Future research should consider the safety of off-label drugs in pediatric, primarily in Indonesia. Clinicians should aware of off-label drugs in pediatric and consider the risk-benefit of the drugs when prescribing to children. The authorities need to regulate the off-label drug prescribing in pediatric, therefore could improve medication safety and quality.
|
|---|---|
| ISSN: | 2549-9068 2579-4558 |